CMMED
ActiveCMMED has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €333k and a net result of €60k. Equity is growing by ~19% per year across the filed fiscal years. Its solvency ranks better than 95% of 19907 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
98
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability91▲+1
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
short-term debt: 0.7% and cash: 78.9% of total assets, and 0.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
99.3%
Return on assets
17.9%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 25-07-2025, 6 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
not confirmed
2024
6 d early
2023
12 d late
2022
13 d early
2021
40 d early
2020
24 d early
2019
5 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€333k▲ 21.7%
2023 · €274k
2018: €76k
2019: €109k
2020: €180k
2021: €217k
2022: €243k
2023: €274k
2018 → 2024
Total assets
€335k▲ 1.6%
2023 · €330k
2018: €308k
2019: €253k
2020: €316k
2021: €338k
2022: €305k
2023: €330k
2018 → 2024
Net result
€60k▲ 8.1%
2023 · €56k
2018: €27k
2019: €33k
2020: €71k
2021: €38k
2022: €47k
2023: €56k
2018 → 2024
Working capital
€281k▲ 42.8%
2023 · €197k
2018: €-44k
2019: €-1k
2020: €78k
2021: €118k
2022: €152k
2023: €197k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€180k-€217k▲ 20.9%€243k▲ 11.9%€274k▲ 12.7%€333k▲ 21.7%
Operating result€98k-€58k▼ 40.9%€71k▲ 21.8%€87k▲ 22.4%€84k▼ 3.1%
Net result€71k-€38k▼ 46.2%€47k▲ 21.3%€56k▲ 19.5%€60k▲ 8.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 3% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €335k
Fixed assets
€52k▼ 32.7%
Current assets
€284k▲ 12.0%
Equity and liabilities €335k
Equity
€333k▲ 21.7%
Debt
€2k▼ 95.7%
The debt ratio falls from 17.1% to 0.7%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€111k▼
2023 · €114k
Cash flow
€87k▲
2023 · €83k
Solvency
99.3%▲
2023 · 82.9%
Debt / equity
0.01▼
2023 · 0.21
ROE
18.1%▼
2023 · 20.3%
ROA
17.9%▲
2023 · 16.9%
Interest coverage
299.47▲
2023 · 208.01
Debt
€2k▼
2023 · €56k
Debt ≤ 1 year
€2k▼
2023 · €56k
Income taxes
€23k▼
2023 · €31k
A ratio outside any meaningful range has been withheld (balance sheet total €335k, equity €333k).
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€330k€335k▲
Fixed assets21/28€77k€52k▼
Intangible fixed assets21€69k€46k▼
Tangible fixed assets22/27€7k€5k▼
Furniture and vehicles24€7k€5k▼
Financial fixed assets28€1k€1k=
Current assets29/58€253k€284k▲
Amounts receivable within one year40/41€28k€13k▼
Trade receivables40€14k€11k▼
Other amounts receivable41€15k€2k▼
Cash at bank and in hand54/58€217k€265k▲
Deferred charges and accrued income490/1€8k€6k▼
Equity and liabilities
Total equity and liabilities10/49€330k€335k▲
Equity10/15€274k€333k▲
Contributions10/11€6k€6k=
Reserves13€209k€269k▲
Tax-exempt reserves132€19k€19k=
Distributable reserves133€190k€250k▲
Profit (loss) carried forward14€59k€58k▼
Amounts payable17/49€56k€2k▼
Amounts payable within one year42/48€56k€2k▼
Current portion of amounts payable after more than one year42€13k-
Trade debts44€2k-
Suppliers440/4€2k-
Taxes, remuneration and social security45€17k€2k▼
Taxes450/3€17k€258▼
Remuneration and social security454/9-€1k
Other amounts payable47/48€23k€880▼
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€28k€27k▼
Other operating charges640/8€1k€1k▲
Gross operating margin9900€115k€112k▼
Operating profit (loss)9901€87k€84k▼
Financial income75/76B€16€0▼
Recurring financial income75€16€0▼
Financial charges65/66B€550€370▼
Recurring financial charges65€550€370▼
Profit (loss) for the period before taxes9903€86k€84k▼
Income taxes67/77€31k€23k▼
Profit (loss) for the period9904€56k€60k▲
Profit (loss) for the period to be appropriated9905€56k€60k▲
Appropriation of the result
Profit (loss) to be appropriated9906€114k€119k▲
Profit (loss) brought forward from the previous period14P€58k€59k▲
Transfer from equity791/2€24k-
Transfer to equity691/2€54k€60k▲
To other reserves6921€54k€60k▲
Profit to be distributed694/7€25k€859▼
Return on contributions (dividend)694€25k€859▼
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
25-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Liquidity times 26current ratio 116.45
Current ratio from 4.50 to 116.45; short-term debt falls from €56k to €2k.
12-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 12 days late
2023
18-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
21-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Equity above €200kEq €217k ▲20.9%
4 profitable years in a row build equity to €217k.
07-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Highest result since 2018net €71k ▲117%
Operating result €98k, net result €71k, both a record.
31-12
Financial
Equity above €150kEq €180k ▲64.7%
3 profitable years in a row build equity to €180k.
05-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 5 days late
2019
31-12
Financial
Equity above €100kEq €109k ▲43.3%
2 profitable years in a row build equity to €109k.
16-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
10-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 10 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Court-Saint-Etienne · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue d'Heuval 201490 Court-Saint-EtienneGround area
1,524 m²
Building footprint
120 m²
Volume, LiDAR
859 m³
Parcel 25023F0636/00E000, Wallonia · tallest building 9.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
CMMED
since 20172.261.087.717
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25023F0636/00E000 | Wallonia | 1,524 m² | 1 · 120 m² | 9.4 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
9845000707B3DE8D5D08
Similar companies · same sector, comparable size
DR MUKENDI MUDIMBIYI MURIEL,MEDECINE GENERALE
BE 0810.306.722
Brussel · Eq €333k
DR. SOFIE SEVENS
BE 0896.905.055
Lommel · Eq €333k
Dr. Luc Timmermans
BE 0751.906.485
Antwerpen · Eq €333k
Dr. Driesens Ans
BE 0768.974.329
Tielt · Eq €334k
DOCTEUR ALAIN DELCOURT
BE 0886.529.817
Evere · Eq €332k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,175 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded19-01-2017
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.